VEGFA and depressive symptom measurement: Lee et al. analyzed 107 Korean patients with nAMD treated with anti-VEGF using the Geriatric Depression Scale [38] and found a 26.2% prevalence of depression, which is consistent with published rates before anti-VEGF treatments became widely available [31].